FreeTrader
عضو محترف
قاعد اضارب فيه على 10 سنت 
ممتاز
ممتاز
دورة المؤشرنت للتحليل الفني
50 دينار كويتي
Spex للمضارب صاحب القلب :)
- بادئ الموضوع circle
- تاريخ البدء
FreeTrader
عضو محترف
ثلاث ضربات كل ضربه 200 دولار تقريبا
نعمه كريم
نعمه كريم
FreeTrader
عضو محترف
كبرنا اللقمه يا مشاري
الضربه ب 500
روح يامتك تك
الضربه ب 500
روح يامتك تك
FreeTrader
عضو محترف
ابشرك مشاري
طبق سهمنا شروط نجمه سهيل
لكن طبقها وطبق الاهداف وفوق الاهداف بيوم واحد هيهيهيههيهي
لكن اليوم راح يكون نفس شغل امس مضاربت خفيفه ولذيذه ... بس لو الله يفكني من الدوام اليوم
...
مافي دكتور هني يعطيني طبيه شهر اجابل السوق واعطيه نسبه هيهيهيهيههي
طبق سهمنا شروط نجمه سهيل
لكن طبقها وطبق الاهداف وفوق الاهداف بيوم واحد هيهيهيههيهي
لكن اليوم راح يكون نفس شغل امس مضاربت خفيفه ولذيذه ... بس لو الله يفكني من الدوام اليوم
...
مافي دكتور هني يعطيني طبيه شهر اجابل السوق واعطيه نسبه هيهيهيهيههي
راعي العوده
عضو نشط
- التسجيل
- 18 يونيو 2003
- المشاركات
- 320
يا شباب السهم عليه خبر اليوم بالواشنطن بوست
Spherix Shares Jump 69% On Diabetes Drug News
By Michael S. Rosenwald
Washington Post Staff Writer
Friday, March 24, 2006; Page D04
Spherix Inc., a Beltsville firm that makes reservations for national parks and is also pursuing a diabetes treatment, saw its shares soar 69 percent yesterday, to $3.52, after announcing that its executives had returned from an overseas trip where they inspected facilities of a clinical research organization in preparation for final human testing of the diabetes drug.
Two weeks earlier, on March 9, Spherix had agreed to sell 585,792 shares of its stock to a Connecticut hedge fund for $2.04 a share, according to documents filed with the
The fund, Forest Investment Management LLC
, in August 2004 had been given an option to purchase the shares at $7 apiece, according to the SEC documents.
Spherix agreed to lower the price on condition that the company buy the stock right away, according to the filings.
The company disclosed the arrangement on March 15.
More than 8 million shares of Spherix stock traded hands yesterday, compared with a daily average of about 200,000 shares over the past year.
Spherix chief executive Richard Levin said the firm lowered Forest's purchase price because the company needed to raise money to pay for the human testing of its potential drug and to maintain the capital needed to keep its stock listed on the Nasdaq National Market board.
Spherix announced in December that federal regulators had given the go-ahead for final testing of its compound to treat Type 2 diabetes, a product the firm's founder and chairman, Gilbert V. Levin, discovered three decades ago while preparing an experiment for travel to Mars.
The stock jumped 287 percent on the news. In the days after, Gilbert Levin sold 61,300 of his 2.4 million shares for between $4.59 and $4.75, cashing out an estimated $285,000. The share price has fallen steadily since then.
About a month later, Spherix announced that it had hired Environ International Inc. to help plan and oversee clinical testing of the diabetes drug.
Levin said the firm's announcement yesterday, which came in a news release, contained little, if any, new information.
"There's nothing in that release that we haven't released before," he said. "It's just shocking to me that we generated this much activity on this news. Most of what we had said in there we had announced before."
He added, "It's our way of letting people know that we were progressing toward doing the clinical trial
Spherix Shares Jump 69% On Diabetes Drug News
By Michael S. Rosenwald
Washington Post Staff Writer
Friday, March 24, 2006; Page D04
Spherix Inc., a Beltsville firm that makes reservations for national parks and is also pursuing a diabetes treatment, saw its shares soar 69 percent yesterday, to $3.52, after announcing that its executives had returned from an overseas trip where they inspected facilities of a clinical research organization in preparation for final human testing of the diabetes drug.
Two weeks earlier, on March 9, Spherix had agreed to sell 585,792 shares of its stock to a Connecticut hedge fund for $2.04 a share, according to documents filed with the
The fund, Forest Investment Management LLC
, in August 2004 had been given an option to purchase the shares at $7 apiece, according to the SEC documents.
Spherix agreed to lower the price on condition that the company buy the stock right away, according to the filings.
The company disclosed the arrangement on March 15.
More than 8 million shares of Spherix stock traded hands yesterday, compared with a daily average of about 200,000 shares over the past year.
Spherix chief executive Richard Levin said the firm lowered Forest's purchase price because the company needed to raise money to pay for the human testing of its potential drug and to maintain the capital needed to keep its stock listed on the Nasdaq National Market board.
Spherix announced in December that federal regulators had given the go-ahead for final testing of its compound to treat Type 2 diabetes, a product the firm's founder and chairman, Gilbert V. Levin, discovered three decades ago while preparing an experiment for travel to Mars.
The stock jumped 287 percent on the news. In the days after, Gilbert Levin sold 61,300 of his 2.4 million shares for between $4.59 and $4.75, cashing out an estimated $285,000. The share price has fallen steadily since then.
About a month later, Spherix announced that it had hired Environ International Inc. to help plan and oversee clinical testing of the diabetes drug.
Levin said the firm's announcement yesterday, which came in a news release, contained little, if any, new information.
"There's nothing in that release that we haven't released before," he said. "It's just shocking to me that we generated this much activity on this news. Most of what we had said in there we had announced before."
He added, "It's our way of letting people know that we were progressing toward doing the clinical trial
FreeTrader
عضو محترف
circle قال:
ماراح يبين معانا الا لما يفتح السوق ماعليك من البريماركت
في مجانين ناطرينه و بويوسف ما يبيع الحبوب الا بعد صلاه المغرب
FreeTrader
عضو محترف
انا حاط امري 2.83 ما مر عليها ولا عبرها لكن وين بروح منو ومن بيوسف راي يقطع عنه الحبوب وبالاخير راح يدور بويوسف بروحه يروح له للبيتcircle قال:
ولا شرايك مشاري
دورة المؤشرنت للتحليل الفني
50 دينار كويتي